Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 14/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8556662 | 0.95 | CCKBR (0.79) | CCKBR | |
| SCHEMBL8867367 | 0.89 | CCKBR (0.88) | CCKBR | |
| SCHEMBL1388061 | 0.89 | CCKBR (0.88) | CCKBR | |
| SCHEMBL8866497 | 0.87 | CCKBR (1.00) | CCKBR | |
| SCHEMBL1388262 | 0.87 | CCKBR (0.85) | CCKBR | |
| SCHEMBL7375453 | 0.86 | CCKBR (1.00) | CCKBR | |
| SCHEMBL1388127 | 0.84 | CCKBR (0.76) | CCKBR | |
| SCHEMBL7926069 | 0.84 | CCKBR (0.79) | CCKBR | |
| SCHEMBL1387839 | 0.81 | CCKBR (1.00) | CCKBR | |
| SCHEMBL8635744 | 0.81 | CCKBR (1.00) | CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6413930-B1 | CONTROLLING EYE MOVEMENT | GLAXO WELLCOME SPA (IT) | 2002-07-02 | — | — | US | claimed |
| EP-0785788-B1 | USE OF CCK-B RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP DISORDERS | GLAXO WELLCOME SPA (IT) | 2001-12-12 | — | — | EP | claimed |
| EP-0710230-B1 | 1,5-BENZODIAZEPINE DERIVATIVES USEFUL AS CCK OR GASTRIN ANTAGONISTS | GLAXO WELLCOME SPA (IT) | 1998-09-16 | — | — | EP | claimed |
| US-5716953-A | MODIFIERS OF GASTRIN AND CHOLECYSTOKININS | GLAXO WELLCOME S.P.A. (IT) | 1998-02-10 | — | — | US | claimed |
| EP-0785788-A1 | USE OF CCK-B RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP DISORDERS | GLAXO WELLCOME S.p.A. (IT) | 1997-07-30 | — | — | EP | claimed |
| EP-0710230-A1 | 1,5-BENZODIAZEPINE DERIVATIVES USEFUL AS CCK OR GASTRIN ANTAGONISTS | GLAXO S.p.A. (IT) | 1996-05-08 | — | — | EP | claimed |
| WO-1996011689-A1 | USE OF CCK-B RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP DISORDERS | GLAXO WELLCOME SPA (IT) | 1996-04-25 | — | — | WO | claimed |
| WO-1995003285-A1 | 1,5-BENZODIAZEPINE DERIVATIVES USEFUL AS CCK OR GASTRIN ANTAGONISTS | GLAXO SPA (IT) | 1995-02-02 | — | — | WO | claimed |
| US-6413930-B1 | CONTROLLING EYE MOVEMENT | GLAXO WELLCOME SPA (IT) | 2002-07-02 | — | — | US | disclosed |
| EP-0785788-B1 | USE OF CCK-B RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP DISORDERS | GLAXO WELLCOME SPA (IT) | 2001-12-12 | — | — | EP | disclosed |
| EP-0710230-B1 | 1,5-BENZODIAZEPINE DERIVATIVES USEFUL AS CCK OR GASTRIN ANTAGONISTS | GLAXO WELLCOME SPA (IT) | 1998-09-16 | — | — | EP | disclosed |
| US-5716953-A | MODIFIERS OF GASTRIN AND CHOLECYSTOKININS | GLAXO WELLCOME S.P.A. (IT) | 1998-02-10 | — | — | US | disclosed |
| EP-0785788-A1 | USE OF CCK-B RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP DISORDERS | GLAXO WELLCOME S.p.A. (IT) | 1997-07-30 | — | — | EP | disclosed |
| EP-0710230-A1 | 1,5-BENZODIAZEPINE DERIVATIVES USEFUL AS CCK OR GASTRIN ANTAGONISTS | GLAXO S.p.A. (IT) | 1996-05-08 | — | — | EP | disclosed |
| WO-1996011689-A1 | USE OF CCK-B RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP DISORDERS | GLAXO WELLCOME SPA (IT) | 1996-04-25 | — | — | WO | disclosed |
| WO-1995003285-A1 | 1,5-BENZODIAZEPINE DERIVATIVES USEFUL AS CCK OR GASTRIN ANTAGONISTS | GLAXO SPA (IT) | 1995-02-02 | — | — | WO | disclosed |